Symphony Capital Partners LP's Net Worth
$96.6 Million
Who is Symphony Capital Partners LP?
Symphony Capital Partners LP has an estimated net worth of $96.6 Million. This is based on reported shares across multiple companies, which include DYNAVAX TECHNOLOGIES CORP, Alexza Pharmaceuticals Inc., and OXIGENE INC.
SEC CIK
Symphony Capital Partners LP's CIK is 0001296059
Past Insider Trading and Trends
2010 was Symphony Capital Partners LP's most active year for acquiring shares with 2 total transactions. Symphony Capital Partners LP's most active month to acquire stocks was the month of March. 2010 was Symphony Capital Partners LP's most active year for disposing of shares, totalling 1 transactions. Symphony Capital Partners LP's most active month to dispose stocks was the month of March. 2010 saw Symphony Capital Partners LP paying a total of $0.00 for 9,722,065 shares, this is the most they've acquired in one year. In 2010 Symphony Capital Partners LP cashed out on 1,283,200 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $10.7
InvestorSymphony Capital Partners LP owns 9,031,431 units of Common Stock, par value $0.001 per share which is worth $96,636,311.70. In the year 2010 Symphony Capital Partners LP filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.28% | 690.63K |
—
|
—
| 9.03M |
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Alexza Pharmaceuticals Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
OXIGENE INC (OTLC) Snapshot price: $0.02296
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +58.42% | 10M |
—
|
—
| 27.12M |
Jul 20
| |||
Form 4
| +193.34% | 11.28M |
$1.11 | $12,522,883.47 | 17.12M |
Dec 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |